Literature DB >> 31270208

Lipogenic SREBP-1a/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms.

Alus M Xiaoli1, Ziyi Song1, Fajun Yang2.   

Abstract

The sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors best known for stimulating the expression of genes encoding key lipogenic enzymes. However, SREBP functions beyond lipid metabolism are less understood. Here, we show that hepcidin antimicrobial peptide (Hamp), encoding the hormone hepcidin essential for iron homeostasis and regulated by dietary iron and inflammation, is a target gene of the two SREBP isoforms SREBP-1a/c. We found that in tissue culture, mature, active, and nuclear forms of the SREBP-1a/c proteins induce endogenous Hamp gene expression and increase the Hamp promoter activity primarily via three regulatory sequences, including an E-box. Moreover, ChIP experiments revealed that SREBP-1a binds to the Hamp gene promoter. Overexpression of nuclear SREBP-1a under the control of the phosphoenolpyruvate carboxylase-1 (Pck1) promoter in mice increased hepatic Hamp mRNA and blood hepcidin levels, and as expected, caused fatty liver. Consistent with the known effects of Hamp up-regulation, SREBP-1a-overexpressing mice displayed signs of dysregulation in iron metabolism, including reduced serum iron and increased hepatic and splenic iron storage. Conversely, liver-specific depletion of the nuclear forms of SREBPs, as in SREBP cleavage-activating protein knockout mice, impaired lipopolysaccharide-induced up-regulation of hepatic Hamp Together, these results indicate that the SREBP-1a/c transcription regulators activate hepcidin expression and thereby contribute to the control of mammalian iron metabolism.
© 2019 Xiaoli et al.

Entities:  

Keywords:  DNA transcription; Hamp; LPS; Mediator; SREBP; hepcidin; inflammation; iron metabolism; lipogenesis; transcription coregulator; transcription factor

Mesh:

Substances:

Year:  2019        PMID: 31270208      PMCID: PMC6709622          DOI: 10.1074/jbc.RA119.009644

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.

Authors:  M Matsuda; B S Korn; R E Hammer; Y A Moon; R Komuro; J D Horton; J L Goldstein; M S Brown; I Shimomura
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

Review 2.  Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis.

Authors:  J D Horton
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

3.  Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors.

Authors:  Valeria Giandomenico; Maria Simonsson; Eva Grönroos; Johan Ericsson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.

Authors:  G Nicolas; M Bennoun; I Devaux; C Beaumont; B Grandchamp; A Kahn; S Vaulont
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 5.  Upstream stimulating factors: highly versatile stress-responsive transcription factors.

Authors:  Sébastien Corre; Marie-Dominique Galibert
Journal:  Pigment Cell Res       Date:  2005-10

6.  An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.

Authors:  Fajun Yang; Bryan W Vought; John S Satterlee; Amy K Walker; Z-Y Jim Sun; Jennifer L Watts; Rosalie DeBeaumont; R Mako Saito; Sven G Hyberts; Shaosong Yang; Christine Macol; Lakshmanan Iyer; Robert Tjian; Sander van den Heuvel; Anne C Hart; Gerhard Wagner; Anders M Näär
Journal:  Nature       Date:  2006-06-21       Impact factor: 49.962

7.  Interleukin-6 induces hepcidin expression through STAT3.

Authors:  Diedra M Wrighting; Nancy C Andrews
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

8.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

9.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

10.  Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.

Authors:  F Diraison; Ph Moulin; M Beylot
Journal:  Diabetes Metab       Date:  2003-11       Impact factor: 6.041

View more
  2 in total

1.  Role of Elevated Intracellular S-Adenosylhomocysteine in the Pathogenesis of Alcohol-Related Liver Disease.

Authors:  Madan Kumar Arumugam; Sharanappa Talawar; Laura Listenberger; Terrence M Donohue; Natalia A Osna; Kusum K Kharbanda
Journal:  Cells       Date:  2020-06-23       Impact factor: 6.600

2.  Cyp1b1 directs Srebp-mediated cholesterol and retinoid synthesis in perinatal liver; Association with retinoic acid activity during fetal development.

Authors:  Meghan Maguire; Michele Campaigne Larsen; Chad M Vezina; Loredana Quadro; Youn-Kyung Kim; Sherry A Tanumihardjo; Colin R Jefcoate
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.